The phrase "adequacy scope" is not commonly used in written English and may not be immediately clear to readers.
It could be used in contexts related to evaluating the sufficiency or appropriateness of a certain range or area, particularly in technical or academic discussions.
Example: "The adequacy scope of the proposed solution must be assessed to ensure it meets all necessary requirements."
Alternatives: "sufficiency range" or "suitability extent".
(Anderson cites Kuhn's 1977 list: empirical adequacy, consistency, scope, external consonance with established theories) (Anderson 3004, 3).
His list of cognitive values included accuracy (empirical adequacy or truth), scope, simplicity, fruitfulness, internal consistency and consistency with other beliefs (conservatism).
In a tiered approach three aspects of these "non-guideline" studies are assessed: the documentation of the study (reliability), the quality of the study design (adequacy) and the scope of examination (validity).
"Despite the University's statement that no misconduct had occurred, many disturbing questions remain about the scope and adequacy of the investigation," says Miller's letter to Jischke.
These ultimate objectives are formulated in the political arena; therefore, the examination of their adequacy is beyond the scope of innovation studies.
This methodology, which is well accepted [ 16, 17, 42], refers to the scope and adequacy with which the instrument reflects the phenomenon of interest, in this case, pain [ 22].
While the HIRG has noted that tools to support HRIS development are growing [ 15, 29- 31], there was also collective recognition that scant baseline information existed regarding the scope and adequacy of existing HRIS implementation worldwide.
Both NEPA and CEQA also have strong provisions for public input, with mandates for public comment periods during which stakeholders including affected communities, public agencies, and project proponents may submit input on the scope and adequacy of the EIA analysis.
Needless to say, as a practical matter, a clinical trial should not begin under the IND process until FDA is satisfied with respect to the scope, design, and adequacy of the proposed trial.
A full assessment of the adequacy of the system would be beyond the scope of this entry.
